Transgender Females Have Lower Tenofovir Diphosphate Concentrations Transgender Females Have Lower Tenofovir Diphosphate Concentrations
Transgender females taking feminizing hormone therapy (FHT) have lower effective rectal tissue concentrations of tenofovir diphosphate active metabolites, compared with cisgender women and men, researchers report.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Diabetes & Endocrinology News Source Type: news
More News: Diabetes | Endocrinology | HIV AIDS | Hormonal Therapy | Hormones | Infectious Diseases | Viread | Women